Gilead Sciences, Inc. GILD announced positive data from its ongoing phase I study evaluating pipeline candidate, lenacapavir.

Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...

Blades, who prefers to remain in the background and deflect attention to ... to this grassroots nonprofit to help people living with HIV. To sustain that level of support without government ...

Dr. Maya Green discusses HIV prevention, addressing racial disparities in healthcare, and the powerful impact of stigma on ...

The value of the 'classical' binary approaches to define genotypic sensitivity and phenotypic sensitivity scores for optimization of background HIV therapy in patients with extensive HIV drug ...

BAGUIO CITY (PIA) — The Department of Health in the Cordillera Administrative Region, through Project Namnama, has expanded its services to schools in continuing efforts to address sexually ...

DnD 2024 backgrounds grant characters stat increases, a starting feat, a range of proficiencies, and a clear backstory. This is a major shake-up to the original Dungeons and Dragons 5e rules, and it ...

Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and tuberculosis. With no family to care for him, Evans was referred to the ...

Since the start of the HIV (human immunodeficiency virus) epidemic back in 1981, an estimated 75.7 million people have been diagnosed with HIV worldwide, and 32.7 million people have died of ...

Children pick anti-retroviral drugs at the Nyumbani Children's Home orphanage that is heavily reliant on foreign donations in Nairobi, Kenya Thursday, Oct. 6, 2025. (AP Photo/Brian Inganga) ...

It is credited with saving more than 26 million lives and is critical to HIV programs in Africa, the continent hardest hit by the disease. There, health officials, experts and people with HIV have ...